课题基金 / 基金详情

Michigan Institute for Clinical and Health Research (MICHR) (TL1)

Michigan Institute for Clinical and Health Research (MICHR) (TL1)
密歇根临床与健康研究所 (MICHR) (TL1)
批准号:
7675407
负责人:
KENNETH J. PIENTA
金额:
$63.06万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-17 至 2012-05-31

项目摘要

项目成果

KENNETH J. PIENTA的其他基金

相似基金

相关文献

中文摘要
翻译
密歇根大学临床与翻译分校 科学奖(UM CTSA)将集中展示世界上最好的研究之一的强大优势 支持和促进临床和转化性研究的机构。UM CTSA将是 设在临床研究促进中心(CACR)。UM的绝大多数人 学校、学院和研究所都参加了UM CTSA,包括商学院, 牙科、医学、护理、信息和公共卫生、工程学院、药学学院、 和文学,科学和艺术,运动学分部,社会研究所和 生命科学研究所。大学拥有的医疗系统,包括大型的、集成的 门诊和住院设施,以及一家管理护理保险公司(M-CARE), 为与UM CTSA建立强有力的伙伴关系做出了重大贡献。UM CTSA的能力 为来自这些不同领域的临床和翻译研究人员提供强大的“第二家” 大学的单位来自于汇集重要的机构资产,并给予UM CTSA 主任和科学审查委员会有权将这些资源分配给有价值的学员, 教职员工和研究项目。除了赠款资源,该机构还捐赠了超过11 每年提供百万美元的实物支助、费用分摊、试点和征聘方案支助,以及 翻新费用。院系和单位每年为教职员工的工作贡献另外1600万英镑,因此 CTSA可以免费为试点研究、教育和“迷你K项目”提供资金 格兰特。为了完成UM CTSA的使命,CACR及其ITS的报告关系和权威 主任(补助金的私人助理)将被修改为跨机构的。CACR将得到加强 通过机构权威为UM CTSA提供“成员资格”(类似于二次任命) 获奖者。我们最近更新的GCRC、K-12和K-30计划将被纳入UM 根据RFA的要求,CTSA。UM CTSA建立在横向研究主题的基础上,这些主题反过来 形成新的临床和翻译方法项目,提供临床和翻译 技术核心,以及试点和合作资助计划。重组后的临床研究单位 将容纳参与者和临床互动。生物统计和设计咨询单位或核心, 伦理、监管知识和支持、社区参与、临床翻译(类型II 《儿科学研究》和《健康差异》。最后,一个强有力的研究性教育和 Trading Core将为教职员工、学生和员工提供职业发展和培训。
英文摘要
The University of Michigan Clinical and Translational Sciences Award (UM CTSA) will focus the formidable strengths of one of the world finest research institutions on supporting and facilitating clinical and translational research. The UM CTSA will be housed in the Center for Advancement of Clinical Research (CACR). The overwhelming majority of UM schools, colleges, and institutes are participating in the UM CTSA, including the Schools of Business, Dentistry, Medicine, Nursing, Information, and Public Health, the Colleges of Engineering, Pharmacy, and Literature, Science and Arts, the Division of Kinesiology, the Institute of Social Research, and the Life Sciences Institute. The University-owned Health System, which includes large, integrated outpatient and inpatient facilities, as well as a managed care insurance company (M-CARE), is contributing significantly to a strong partnership with the UM CTSA. The ability of the UM CTSA to provide a robust "second home" for clinical and translational researchers from these many different units of the University is derived from pooling significant institutional assets, and giving the UM CTSA Director and Scientific Review Committee the authority to distribute these resources to worthy trainees, faculty, and research projects. In addition to the grant resources, the institution is contributing over 11 million per year of in-kind support, cost-sharing, support of pilot and recruitment programs, and renovation costs. Departments and units are contributing another 16 million annually in faculty effort, so that the CTSA can grant effort for pilot studies, education and "mini-K programs" without cost to the grant. To accomplish the mission of the UM CTSA, the reporting lines and authority of CACR and its director (the PI of the grant) will be modified to be trans-institutional. CACR will be strengthened through institutional authority to offer "membership" (akin to secondary appointments) for UM CTSA awardees. Our recently renewed GCRC, K-12, and K-30 programs will be incorporated into the UM CTSA, as required by the RFA. The UM CTSA is built on cross-cutting Research Themes, which in turn form Novel Clinical and Translational Methodology Projects, the provision of Clinical and Translational Technical Cores, and a Pilot and Collaborative Grant Program. A reconfigured Clinical Research Unit will house Participant and Clinical Interactions. Consultative Units or Cores in Biostatistics and Design, Ethics, Regulatory Knowledge and Support, Community Engagement, Clinical Translation (Type II Translation), Research in Pediatrics, and Health Disparities. Finally, a strong Research Education and Training Core will provide career development and training for faculty, students, and staff.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Johns Hopkins Physical Sciences Oncology Center
  • 批准号:
    9339630
  • 项目类别:
  • 资助金额:
    $211.84万
  • 财政年份:
    2016
  • 负责人:
    KENNETH J. PIENTA
  • 依托单位:
The Johns Hopkins Physical Sciences Oncology Center
  • 批准号:
    9753736
  • 项目类别:
  • 资助金额:
    $174.51万
  • 财政年份:
    2016
  • 负责人:
    KENNETH J. PIENTA
  • 依托单位:
The JAK2 V617F mutation within B cells and T cells leads to a pro-tumor microenvironment
  • 批准号:
    9903606
  • 项目类别:
  • 资助金额:
    $7.38万
  • 财政年份:
    2016
  • 负责人:
    KENNETH J. PIENTA
  • 依托单位:
The Johns Hopkins Physical Sciences Oncology Center
  • 批准号:
    10016193
  • 项目类别:
  • 资助金额:
    $202.01万
  • 财政年份:
    2016
  • 负责人:
    KENNETH J. PIENTA
  • 依托单位:
海外基金